article June 13, 2021
2 Key Ways to Improve Patient Recruitment of Minorities In Clinical Trials – A Participant’s Perspective
From the perspective of COVID-19 clinical trials participant, John Reaves, there are two key strategies for improving minority participation in clinical research: heighten communication with patients and communities, and acknowledge, address, and take action again current biases. At Javara, delivering access to clinical research as a care option for all and diversifying participation are at the core of everything we do, and feedback and insight from participants like John is truly invaluable. Click the link below to read John’s full story:
Javara is the leading Integrated Research Organization (IRO) partnering with large healthcare organizations in local communities across the US to integrate clinical research into clinical care. Our access to broad diverse patient populations through their trusted physicians ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. Our team includes experienced clinical research leaders who have collectively led 10,000+ trials and engaged 200,000+ patients in clinical trials. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.
Javara Media Contact: